The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Germline BRCA1 mutations increase prostate cancer risk
Open accessAbstract
BACKGROUND: Prostate cancer (PrCa) is one of the most common cancers affecting men but its aetiology is poorly understood. Family history of PrCa, particularly at a young age, is a strong risk factor. There have been previous reports of increased PrCa risk in male BRCA1 mutation carriers in female breast cancer families, but there is a controversy as to whether this risk is substantiated. We sought to evaluate the role of germline BRCA1 mutations in PrCa predisposition by performing a candidate gene study in a large UK population sample set. METHODS: We screened 913 cases aged 36–86 years for germline BRCA1 mutation, with the study enriched for cases with an early age of onset. We analysed the entire coding region of the BRCA1 gene using Sanger sequencing. Multiplex ligation-dependent probe amplification was also used to assess the frequency of large rearrangements in 460 cases. RESULTS: We identified 4 deleterious mutations and 45 unclassified variants (UV). The frequency of deleterious BRCA1 mutation in this study is 0.45%; three of the mutation carriers were affected at age 65 years and one developed PrCa at 69 years. Using previously estimated population carrier frequencies, deleterious BRCA1 mutations confer a relative risk of PrCa of ~3.75-fold, (95% confidence interval 1.02–9.6) translating to a 8.6% cumulative risk by age 65. CONCLUSION: This study shows evidence for an increased risk of PrCa in men who harbour germline mutations in BRCA1. This could have a significant impact on possible screening strategies and targeted treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Primer3 on the WWW for General Users and for Biologist Programmers
Rozen, S., & Skaletsky, H. (2003) · Bioinformatics Methods and Protocols · doi:10.1385/1-59259-192-2:365 · Cited by 15,013
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Wang, K., Li, M., & Hakonarson, H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq603 · Cited by 14,621
A method and server for predicting damaging missense mutations.
Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P., Kondrashov, A. S., & Sunyaev, S. R. (2010) · Nature Methods · doi:10.1038/nmeth0410-248 · Cited by 13,194
dbSNP: the NCBI database of genetic variation
Sherry, S. T. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.1.308 · Cited by 7,502
Kumar, P., Henikoff, S., & Ng, P. C. (2009) · Nature Protocols · doi:10.1038/nprot.2009.86 · Cited by 6,521
Lichtenstein, P., Holm, N. V., Verkasalo, P. K., Iliadou, A., Kaprio, J., Koskenvuo, M., Pukkala, E., Skytthe, A., & Hemminki, K. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007133430201 · Cited by 4,114
Estimates of the cancer incidence and mortality in Europe in 2006
Ferlay, J., Autier, P., Boniol, M., Heanue, M., Colombet, M., & Boyle, P. (2007) · Annals of Oncology · doi:10.1093/annonc/mdl498 · Cited by 4,036
MutationTaster evaluates disease-causing potential of sequence alterations
Schwarz, J. M., Rödelsperger, C., Schuelke, M., & Seelow, D. (2010) · Nature Methods · doi:10.1038/nmeth0810-575 · Cited by 2,975
Detection of nonneutral substitution rates on mammalian phylogenies
Pollard, K. S., Hubisz, M. J., Rosenbloom, K. R., & Siepel, A. (2010) · Genome Research · doi:10.1101/gr.097857.109 · Cited by 2,353
Cancer Risks in BRCA2 Mutation Carriers
Breast Cancer Linkage Consortium, T. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.15.1310 · Cited by 1,527
Cancer Incidence in BRCA1 Mutation Carriers
Thompson, D. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.18.1358 · Cited by 1,096
Identification of deleterious mutations within three human genomes
Chun, S., & Fay, J. C. (2009) · Genome Research · doi:10.1101/gr.092619.109 · Cited by 1,049
LOVD v.2.0: the next generation in gene variant databases
Fokkema, I. F. A. C., Taschner, P. E. M., Schaafsma, G. C. P., Celli, J., Laros, J. F. J., & den Dunnen, J. T. (2011) · Human Mutation · doi:10.1002/humu.21438 · Cited by 1,048
Assessing Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial
Thompson, I. M., Ankerst, D. P., Chi, C., Goodman, P. J., Tangen, C. M., Lucia, M. S., Feng, Z., Parnes, H. L., & Coltman, C. A. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj131 · Cited by 938
Multiple loci identified in a genome-wide association study of prostate cancer
Thomas, G., Jacobs, K. B., Yeager, M., Kraft, P., Wacholder, S., Orr, N., Yu, K., Chatterjee, N., Welch, R., Hutchinson, A., et al. (2008) · Nature Genetics · doi:10.1038/ng.91 · Cited by 900
Multiple newly identified loci associated with prostate cancer susceptibility
Collaborators, T. U. G. P. C. S., Eeles, R. A., British Association of Urological Surgeons' Section of Oncology, Collaborators, T. U. P. S., Kote-Jarai, Z., Giles, G. G., Olama, A. A. A., Guy, M., Jugurnauth, S. K., Mulholland, S., et al. (2008) · Nature Genetics · doi:10.1038/ng.90 · Cited by 844
Self-citationdbNSFP: A lightweight database of human nonsynonymous SNPs and their functional predictions
Liu, X., Jian, X., & Boerwinkle, E. (2011) · Human Mutation · doi:10.1002/humu.21517 · Cited by 823
Liu, X., Jian, X., & Boerwinkle, E. (2013) · Human Mutation · doi:10.1002/humu.22376 · Cited by 587
A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes
Antoniou, A. C., Pharoah, P. D. P., McMullan, G., Day, N. E., Stratton, M. R., Peto, J., Ponder, B. J., & Easton, D. F. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600008 · Cited by 495
Self-citationVariation in Cancer Risks, by Mutation Position, in BRCA2 Mutation Carriers
Thompson, D., & Easton, D. (2001) · The American Journal of Human Genetics · doi:10.1086/318181 · Cited by 489
Self-citationBreast cancer risk associated with BRCA1 and BRCA2 in diverse populations
Fackenthal, J. D., & Olopade, O. I. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2054 · Cited by 488
Collaborators, T. U., Kote-Jarai, Z., Leongamornlert, D., Saunders, E., Tymrakiewicz, M., Castro, E., Mahmud, N., Guy, M., Edwards, S., O'Brien, L., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.383 · Cited by 399
Self-citationWildeman, M., van Ophuizen, E., den Dunnen, J. T., & Taschner, P. E. M. (2008) · Human Mutation · doi:10.1002/humu.20654 · Cited by 392
Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer
Gudmundsson, J., Sulem, P., Rafnar, T., Bergthorsson, J. T., Manolescu, A., Gudbjartsson, D., Agnarsson, B. A., Sigurdsson, A., Benediktsdottir, K. R., Blondal, T., et al. (2008) · Nature Genetics · doi:10.1038/ng.89 · Cited by 370
Mathe, E. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj518 · Cited by 340
Neuhausen, S. L., Godwin, A. K., Gershoni-Baruch, R., Schubert, E., Garber, J., Stoppa-Lyonnet, D., Olah, E., Csokay, B., Serova, O., Lalloo, F., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301885 · Cited by 335
Self-citationTavtigian, S. V., Byrnes, G. B., Goldgar, D. E., & Thomas, A. (2008) · Human Mutation · doi:10.1002/humu.20896 · Cited by 227
Self-citationThe Breast Cancer Information Core: Database design, structure, and scope
Szabo, C., Masiello, A., Ryan, J. F., The BIC Consortium, & Brody, L. C. (2000) · Human Mutation · doi:10.1002/1098-1004(200008)16:2<123::aid-humu4>3.0.co;2-y · Cited by 193
Mancini, D. N., Rodenhiser, D. I., Ainsworth, P. J., O'Malley, F. P., Singh, S. M., Xing, W., & Archer, T. K. (1998) · Oncogene · doi:10.1038/sj.onc.1201630 · Cited by 190
BRCA Mutations and Risk of Prostate Cancer in Ashkenazi Jews
Kirchhoff, T., Kauff, N. D., Mitra, N., Nafa, K., Huang, H., Palmer, C., Gulati, T., Wadsworth, E., Donat, S., Robson, M. E., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0604 · Cited by 165
Contribution of BRCA1 and BRCA2 Mutations to Breast and Ovarian Cancer in Pakistan
Liede, A., Malik, I. A., Aziz, Z., Rios, P. D. L., Kwan, E., & Narod, S. A. (2002) · The American Journal of Human Genetics · doi:10.1086/342506 · Cited by 159
Studies of Genetic Factors in Prostate Cancer in a Twin Population
Grönberg, H., Damber, L., & Damber, J. (1994) · The Journal of Urology · doi:10.1016/s0022-5347(17)32452-7 · Cited by 145
Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden.
Jóhannsson, Ó. Þ., Ostermeyer, E. A., Håkansson, S., Friedman, L. S., Johansson, U., Sellberg, G., Brøndum‐Nielsen, K., Sele, V., Olsson, H. L., King, M., et al. (1996) · PubMed · Cited by 130
Prevalence of BRCA1 Mutation Carriers among U.S. Non-Hispanic Whites
Whittemore, A. S., Gong, G. D., John, E. M., McGuire, V. M., Li, F. P., Ostrow, K. L., DiCioccio, R. A., Felberg, A., & West, D. W. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.2078.13.12 · Cited by 124
Goh, C. L., Schumacher, F. R., Easton, D. F., Muir, K. R., Henderson, B. E., Kote‐Jarai, Z., & Eeles, R. A. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2012.02511.x · Cited by 98
Self-citationMacInnis, R. J., Antoniou, A. C., Eeles, R. A., Severi, G., Olama, A. A. A., McGuffog, L., Kote‐Jarai, Z., Guy, M., O'Brien, L. T., Hall, A. L., et al. (2011) · Genetic Epidemiology · doi:10.1002/gepi.20605 · Cited by 77
Self-citationClassification of missense substitutions in the BRCA genes: A database dedicated to Ex-UVs
Vallée, M., Francy, T. C., Judkins, M. K., Babikyan, D., Lesueur, F., Gammon, A., Goldgar, D. E., Couch, F. J., & Tavtigian, S. V. (2011) · Human Mutation · doi:10.1002/humu.21629 · Cited by 66
Self-citationFunctional analysis of CpG methylation in the BRCA1 promoter region
Mancini, D. N., Butcher, D. T., Robinson, D. P., Archer, T., & Rodenhiser, D. I. (2001) · Oncogene · doi:10.1038/sj.onc.1204697 · Cited by 58
A CREB site in the BRCA1 proximal promoter acts as a constitutive transcriptional element
Atlas, E., Stramwasser, M., & Mueller, C. R. (2001) · Oncogene · doi:10.1038/sj.onc.1204890 · Cited by 57
No germline mutations in the dimerization domain of MXI1 in prostate cancer clusters
Collaborators, T. C. U. F. P. C. S., Edwards, S., Dearnaley, D., Ardern-Jones, A. T., Hamoudi, R., Easton, D., Ford, D., Shearer, R. J., Dowe, A., & Eeles, R. A. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.498 · Cited by 38
Self-citationEeles, R., Dearnaley, D., Ardern-jones, A., Shearer, R., Easton, D., Ford, D., Edwards, S., & Dowe, A. (1997) · British Journal of Urology · doi:10.1111/j.1464-410x.1997.tb00795.x · Cited by 38
Self-citationAge-dependent penetrance of different germline mutations in the BRCA1 gene
Al-Mulla, F., Bland, J., Serratt, D., Miller, J., Chu, C., & Taylor, G. (2009) · Journal of Clinical Pathology · doi:10.1136/jcp.2008.062646 · Cited by 34
Fachal, L., Gómez‐Caamaño, A., Celeiro‐Muñoz, C., Peleteiro, P., Blanco, A., Carballo, A. M., Forteza, J., Carracedo, Á., & Vega, A. I. (2011) · The Prostate · doi:10.1002/pros.21394 · Cited by 27
Berruti, A., Sperone, P., Fasolis, G., TORTA, M., Fontana, D., Dogliotti, L., & Angeli, A. (1997) · The Prostate · doi:10.1002/(sici)1097-0045(19971201)33:4<240::aid-pros3>3.0.co;2-l · Cited by 25
Cited by
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
Pritchard, C. C., Mateo, J., Walsh, M. F., De Sarkar, N., Abida, W., Beltran, H., Garofalo, A., Gulati, R., Carreira, S., Eeles, R., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603144 · Cited by 1,680
Self-citationBreast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
Mohler, J. L., Antonarakis, E. S., Armstrong, A. J., D’Amico, A. V., Davis, B. J., Dorff, T., Eastham, J. A., Enke, C. A., Farrington, T. A., Higano, C. S., et al. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.0023 · Cited by 1,532
Daly, M. B., Pal, T., Berry, M. P., Buys, S. S., Dickson, P., Domchek, S. M., Elkhanany, A., Friedman, S., Goggins, M., Hutton, M. L., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0001 · Cited by 1,112
Attard, G., Parker, C., Eeles, R. A., Schröder, F., Tomlins, S. A., Tannock, I., Drake, C. G., & de Bono, J. S. (2016) · The Lancet · doi:10.1016/s0140-6736(14)61947-4 · Cited by 905
Self-citation
Metadata
- Authors
- Collaborators, T. U., Leongamornlert, D., Mahmud, N., Tymrakiewicz, M., Saunders, E., Dadaev, T., Castro, E., Goh, C., Govindasami, K., Guy, M., O'Brien, L., Sawyer, E., Hall, A., Wilkinson, R., Easton, D., Goldgar, D., Eeles, R., & Kote-Jarai, Z.
- Venue
- British Journal of Cancer
- Published
- 2012-04-19
- Volume
- 106
- Issue
- 10
- Pages
- 1697-1701
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2112211663
- Cited by
- 302
- References
- 44
- FWCI
- 10.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.